Atorvastatin attenuated post-ischemic pathologic remodeling by suppressing the levels of phosphorylated AKT2, NBA1, and phosphorylated SPK1, macrophage recruitment, apoptosis, collagen deposition, and increased angiogenesis in the infarction area. The gene discussed is SPHK1; the disease is infarction.